A randomised controlled trial of ondansetron to prevent shivering in women undergoing combined spinal epidural anaesthesia for elective caesarean section
Women undergoing combined spinal epidural for elective caesarean section, ondansetron 8mg versus placebo to prevent perioperative shivering.
Dr Roger Browning
120 participants
Jun 15, 2009
Interventional
Conditions
Summary
In Australia Caesarean section is most commonly performed under regional anaesthesia, usually spinal or epidural. These techniques are associated with a significant incidence of shivering which can cause the mother significant distress, prevent her from holding her baby & interfere with monitoring of blood pressure and other vital signs. Ondansetron is a widely used anti – nausea drug, with a good safety profile and very few adverse effects. It has been shown to reduce the incidence & severity of shivering in non obstetric patients undergoing regional or general anaesthesia. We plan to investigate whether the prophylactic administration of ondansetron prior to regional anaesthesia will decrease the incidence and severity of shivering in women undergoing elective caesarean section.
Eligibility
Inclusion Criteria3
- American Society of Anesthesiologists (ASA) Score 1 or 2
- years of age or older
- Elective caeasarean section under combined spinal epidural anaesthesia
Exclusion Criteria7
- Preoperative use of ondansetron, clonidine, pethidine or tramadol
- Contraindication to combined spinal epidural anaesthesia
- Preoperative shivering
- Intolerance or allergy to ondansetron
- Failure to find subarachnoid space during combined spinal epidural anaesthesia
- Conversion to general anaesthesia
- Adminstration of intrathecal or epidural morphine
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ondansetron 8mg intravenously over 5 - 10 seconds
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000445279